| [1] |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149: 1060-1072.
|
| [2] |
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156:317-331.
|
| [3] |
姜学东,李文雅.Erastin诱导人非小细胞肺癌细胞系A549凋亡[J].基础医学与临床,2021,41:1313-1317.
|
| [4] |
Song Z, Xiang X, Li J, et al. Ruscogenin induces ferroptosis in pancreatic cancer cells[J]. Oncol Rep, 2020, 43:516-524.
|
| [5] |
Guan Z, Chen J, Li X, et al. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation[J]. Biosci Rep, 2020, 40: BSR20201807. doi:10.1042/BSR20201807.
|
| [6] |
Yuan B, Liao F, Shi ZZ, et al. Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/SLC7A11 Axis[J]. Onco Targets Ther, 2020, 13: 10829-10840.
|
| [7] |
Liu G, Kuang S, Cao R, et al. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway[J]. FASEB J, 2019, 33: 10089-10103.
|
| [8] |
Li Y, Yan H, Xu X, et al. Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway[J]. Oncol Lett, 2020, 19: 323-333.
|
| [9] |
Sehm T, Fan Z, Ghoochani A, et al. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema[J]. Oncotarget, 2016, 7: 36021-36033.
|
| [10] |
Li M, Chen X, Wang X, et al. RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction[J]. Biochem Pharmacol, 2021, 192: 114741. doi:10.1016/j.bcp.2021.114741.
|
| [11] |
Jiang Z, Lim SO, Yan M, et al. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis[J]. J Clin Invest, 2021, 131:e139434. doi:10.1172/JCI139434.
|
| [12] |
Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy[J]. Nature, 2019, 569: 270-274.
|
| [13] |
Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy[J]. Small, 2020, 16: e2001704. doi:10.1002/smll.202001704.
|
| [14] |
Ping Z, Peng Y, Lang H, et al. Oxidative stress in radiation-induced cardiotoxicity[J]. Oxid Med Cell Longev, 2020, 2020: 1-15.
|
| [15] |
Lang X, Green MD, Wang W, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11[J]. Cancer Discov, 2019, 9: 1673-1685.
|
| [16] |
Ye LF, Chaudhary KR, Zandkarimi F, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers[J]. ACS Chem Biol, 2020, 15: 469-484.
|
| [17] |
Li X, Zhuang X, Qiao T. Role of ferroptosis in the process of acute radiation-induced lung injury in mice[J]. Biochem Biophys Res Commun, 2019,519: 240-245.
|
| [18] |
Shibata Y, Yasui H, Higashikawa K, et al. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo[J]. PLoS One, 2019;14:e0225931. doi:10.1371/journal.pone.0225931.
|
| [19] |
Zhang Y, Tan H, Daniels JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model[J]. Cell Chem Biol, 2019, 26: 623-633.
|
| [20] |
Klein S, Wegmann M, Distel LVR, et al. APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy[J]. Biophys Res Commun, 2018, 498: 855-861.
|
| [21] |
Wan X, Song L, Pan W, et al. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy[J].ACS Nano, 2020, 14: 11017-11028.
|
